Moneycontrol PRO
you are here: HomeNewsBusiness

Boeing says it will need to borrow more money on coronavirus fallout

"Our first priority is going to be to pay that back, the principle and the interest that goes with it."

April 28, 2020 / 07:46 AM IST

Boeing Co will need to borrow more money over the next six months and does not expect to pay dividends again for years, as the U.S. planemaker wrestles with industry fallout from the coronavirus and the grounding of its 737 MAX jet, chief executive Dave Calhoun told shareholders on Monday.

"We know we're going to have to borrow more money in the next six months in order to get through this really difficult moment, to provide the right liquidity to the supply chain that represents our industry," Calhoun said during the company's virtual annual general meeting.

"Our first priority is going to be to pay that back, the principle and the interest that goes with it."

Boeing would continue ordering parts and services from its suppliers to ensure the smaller companies have enough business to keep them afloat during the downturn, he said.

We have to keep that flow of money going to the supply chain so that they have some predictability around how they operate.”

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Boeing is trying to bring its 737 MAX jet back into service after two fatal crashes, even as the aviation industry slumps because of the coronavirus, which has dried up demand for passenger air travel.

Calhoun said Boeing expects it will take two to three years for travel to return to 2019 levels and an additional few years more for the industry's long-term trend growth to return.

Calhoun warned shareholders he is not confident Boeing will resume paying dividends in the medium-term.

"That process could take three to five years... It's going to be a while before dividends come back."

The largest U.S. planemaker, which reports first-quarter earnings Wednesday, last month drew down its entire $13.8 billion credit line and suspended its dividend. Boeing's first-quarter deliveries were a third of the 149 seen a year earlier and the lowest since 1984 for the first quarter.

Boeing shares closed down 0.3% to $128.68.


The company also cancelled a $4.2 billion deal for Embraer SA's commercial aviation division over the weekend, prompting the Brazilian company to initiate arbitration.

Earlier in the meeting, Calhoun said the company's negotiation for Embraer's regional jet-making division was no longer helpful.

“We worked diligently for two years to finalize the transaction, but ultimately we could not come to a resolution around critical unsatisfied conditions for the deal," he said.

Boeing said it was confident of its legal right to terminate the agreement.

Industry sources have said Boeing was interested in Embraer mainly for access to lower-cost engineers and new manufacturing options, but it is now pondering cutting 10% of its workforce while also seeking U.S. federal help for the aerospace sector.

Boeing in March called for a "minimum of $60 billion in access to public and private liquidity, including loan guarantees, for the aerospace manufacturing industry. The company has not said if it will seek government loans or tap a $17 billion fund for national security-related companies.

Boeing also said on Monday it will resume 787 productions in South Carolina next week after it resumed commercial aeroplane production last week in Washington state.

On Monday, shareholders also narrowly approved a measure backing a policy requiring an independent board chairman. Boeing has had a separate chairman and chief executive since October.

Boeing said each of the company's 12 board nominees received a majority of votes from shareholders, though five directors got a significant number of no votes.

Two proxy advisers, Glass Lewis and Institutional Shareholder Services (ISS), had recommended that Boeing shareholders vote against key board members to show objections to the company's handling of the 737 MAX crisis.

Calhoun did not repeat the company's long-standing timetable of a mid-year return to service approval by regulators for the 737 MAX that has been grounded since March 2019 after two crashes killed 346 people. Reuters reported last week a key certification test flight may not occur until late May or later. "We remain confident in the MAX," Calhoun said.

first published: Apr 28, 2020 07:43 am